IL41767A - Injectable composition for tagging with technetium-99m and its preparation - Google Patents

Injectable composition for tagging with technetium-99m and its preparation

Info

Publication number
IL41767A
IL41767A IL41767A IL4176773A IL41767A IL 41767 A IL41767 A IL 41767A IL 41767 A IL41767 A IL 41767A IL 4176773 A IL4176773 A IL 4176773A IL 41767 A IL41767 A IL 41767A
Authority
IL
Israel
Prior art keywords
macroprotein
set forth
particles
composition
divalent tin
Prior art date
Application number
IL41767A
Other languages
English (en)
Other versions
IL41767A0 (en
Original Assignee
Mallinckrodt Chemical Works
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Chemical Works filed Critical Mallinckrodt Chemical Works
Publication of IL41767A0 publication Critical patent/IL41767A0/xx
Publication of IL41767A publication Critical patent/IL41767A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/081—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the protein being an albumin, e.g. human serum albumin [HSA], bovine serum albumin [BSA], ovalbumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1255—Granulates, agglomerates, microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL41767A 1972-03-20 1973-03-13 Injectable composition for tagging with technetium-99m and its preparation IL41767A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US236159A US3863004A (en) 1972-03-20 1972-03-20 Denatured macroprotein with divalent tin for tagging with technetium-99m and method of preparation

Publications (2)

Publication Number Publication Date
IL41767A0 IL41767A0 (en) 1973-05-31
IL41767A true IL41767A (en) 1976-06-30

Family

ID=22888369

Family Applications (1)

Application Number Title Priority Date Filing Date
IL41767A IL41767A (en) 1972-03-20 1973-03-13 Injectable composition for tagging with technetium-99m and its preparation

Country Status (10)

Country Link
US (1) US3863004A (enrdf_load_stackoverflow)
JP (1) JPS5328971B2 (enrdf_load_stackoverflow)
AU (1) AU472255B2 (enrdf_load_stackoverflow)
BE (1) BE796962A (enrdf_load_stackoverflow)
DE (1) DE2314059A1 (enrdf_load_stackoverflow)
FR (1) FR2182880B1 (enrdf_load_stackoverflow)
GB (1) GB1409176A (enrdf_load_stackoverflow)
IL (1) IL41767A (enrdf_load_stackoverflow)
IT (1) IT989625B (enrdf_load_stackoverflow)
NL (1) NL7303842A (enrdf_load_stackoverflow)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3968221A (en) * 1972-05-05 1976-07-06 Medi-Physics, Inc. 99M-Technetium labeled tin colloid radiopharmaceuticals
US4024233A (en) * 1972-06-05 1977-05-17 Medi-Physics, Inc. 99M-technetium labeled macroaggregated human serum albumin pharmaceutical
US3987157A (en) * 1974-08-29 1976-10-19 Union Carbide Corporation Technetium 99-m labeled radio-diagnostic agents employing stannous tartrate and method of preparation
US3992513A (en) * 1975-01-07 1976-11-16 Atomic Energy Of Canada Limited Labelled phospholipid material colloidially dispersed and sized to localize at preselected organs
US4057617A (en) * 1975-05-15 1977-11-08 Abramovici J Method of labeling proteins with technetium
GB1535847A (en) * 1976-03-19 1978-12-13 Radiochemical Centre Ltd Technetium-99m labelled tin colloid for body scanning
US4094965A (en) * 1977-04-01 1978-06-13 New England Nuclear Corporation Diagnostic agents containing albumin and method for making same
US4226846A (en) * 1977-04-01 1980-10-07 New England Nuclear Corporation Albumin microaggregates for radioactive scanning of reticuloendothelial systems
US4337240A (en) * 1978-04-20 1982-06-29 New England Nuclear Corporation Denatured albumin complexes for radioscintigraphic imaging and evaluation of reticuloendothelial systems
DE3060377D1 (en) * 1979-08-29 1982-07-01 Nihon Mediphysics Co Ltd 2-oxopropionaldehyde bis(thiosemicarbazone)derivatives and their production and use
JPS5645790U (enrdf_load_stackoverflow) * 1979-09-17 1981-04-24
US4406876A (en) * 1980-10-14 1983-09-27 Research Foundation Of The State Univ. Of New York Sulfur free small-particle production of technetium sulfur colloid
IT1194135B (it) * 1981-01-05 1988-09-14 Novo Industri As Composizioni di plasmina stabilizzata e metodo per la loro preparazione
CH652599A5 (de) * 1981-08-28 1985-11-29 Solco Basel Ag Verfahren zur herstellung physiologisch abbaubarer kolloidaler, human-serumalbumin enthaltender produkte und ihre verwendung.
JPS61103841A (ja) * 1984-10-26 1986-05-22 Nippon Mejifuijitsukusu Kk 放射性テクネチウム標識に供する安定な塩化第一スズ組成物
US5013720A (en) * 1986-05-06 1991-05-07 Abbott Laboratories SAP-6-Val proteins and methods
DE3728599A1 (de) * 1986-12-10 1988-06-23 Hoechst Ag Verfahren zur herstellung einer mit technetium-99m-markierten organspezifischen substanz
US5071965A (en) * 1988-07-19 1991-12-10 Mallinckrodt Medical, Inc. Novel tc-99m complexes
US5096696A (en) * 1990-02-05 1992-03-17 The Research Foundation Of State University Of New York Binding of radiolabeled albumin fragments to fibrin clots
US5137709A (en) * 1991-02-15 1992-08-11 The Dow Chemical Company Layered mixed metal hydroxides for the stabilization of radioactive colloids
US5306482A (en) * 1991-04-09 1994-04-26 Merck Frosst Canada, Inc. Radiopharmaceutical bacteriostats
GB9107628D0 (en) * 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
AU3783893A (en) * 1992-02-28 1993-09-13 Stanley E. Order Use of aggregated proteins to prolong retention time of a therapeutic agent adjacent a targeted site such as a tumor
US6730286B2 (en) * 2001-02-28 2004-05-04 Bracco Diagnostics, Inc. Manufacturing process to control particle size
DE10317461A1 (de) * 2003-04-16 2004-10-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
FI20040240A0 (fi) * 2004-02-13 2004-02-13 Nokia Corp Laskutusinformaation tuottaminen viestintäjärjestelmässä

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3663686A (en) * 1968-04-24 1972-05-16 Minnesota Mining & Mfg Biodegradable radioactive particles
US3663687A (en) * 1968-06-26 1972-05-16 Minnesota Mining & Mfg Biodegradable parenteral microspherules
US3725295A (en) * 1971-07-20 1973-04-03 Atomic Energy Commission Technetium labeling
CS208162B2 (en) * 1971-07-20 1981-08-31 Thomas A Haney Method of making the macroagregates of the technicium-99m,albumine and tin ion

Also Published As

Publication number Publication date
BE796962A (fr) 1973-09-19
JPS5328971B2 (enrdf_load_stackoverflow) 1978-08-17
AU472255B2 (en) 1976-05-20
DE2314059A1 (de) 1973-10-04
FR2182880A1 (enrdf_load_stackoverflow) 1973-12-14
FR2182880B1 (enrdf_load_stackoverflow) 1976-04-09
GB1409176A (en) 1975-10-08
IT989625B (it) 1975-06-10
JPS4954517A (enrdf_load_stackoverflow) 1974-05-27
NL7303842A (enrdf_load_stackoverflow) 1973-09-24
AU5337573A (en) 1974-09-19
IL41767A0 (en) 1973-05-31
US3863004A (en) 1975-01-28

Similar Documents

Publication Publication Date Title
IL41767A (en) Injectable composition for tagging with technetium-99m and its preparation
EP0091258B2 (en) Method for stabilizing tumor necrosis factor and a stable aqueous solution or powder containing said factor
Leslie et al. Folate binding by the brush border membrane proteins of small intestinal epithelial cells
US4495288A (en) Method of culturing anchorage dependent cells
Vacquier et al. Isolation of bindin: the protein responsible for adhesion of sperm to sea urchin eggs.
Shotton et al. Appearance and distribution of surface proteins of the human erythrocyte membrane. An electron microscope and immunochemical labeling study.
CA1172961A (en) Process for producing substances produced by cells
US4289756A (en) Physiological preparation containing loaded cells of expanded volume in suspension, for preferential accumulation in spleen and liver
JPS6310668A (ja) 水和により分散重合体粒子を含有する水性ゲルに転換し得る乾燥材料
GB1323000A (en) Method of recovering proteins from microbial cells
US3832338A (en) Orgotein production using a buffer solution containing divalent metal salts
US3843444A (en) Membrane separation process
Cairo et al. Synergistic effect of heparin and chemotactic factor on polymorphonuclear leukocyte aggregation and degranulation
KR840002657A (ko) 인터페론 조성물의 제조방법
CA2026610A1 (en) Chemically modified allergens and process for the preparation thereof
Rachel The effect of prostaglandin on tumour implantation
US3687927A (en) Orgotein isolation process employing single ion exchange resin having both acidic and basic groups
Wilkins Interaction of charged colloids with the RES
DE2949407A1 (de) Verfahren zur gewinnung von (alpha) -2-sb-glykoprotein
JPS5959625A (ja) ガン壊死因子を安定化する方法
SE430753B (sv) Kombinerat haemophilus influenzae-bordetella pertussis-vaccin
GB1471006A (en) Preparation of albumin
Jamieson et al. Membrane glycoproteins of blood platelets
EP0251121A3 (de) Verfahren zur Auslösung der Bildung von Antikörpern
JP2861655B2 (ja) ヒト尿性トリプシンインヒビター含有液状製剤及びその製造方法